Tower Research Capital (TRC)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,675
| Closed | -$228K | – | 5347 |
|
|
2020
Q2 | $228K | Buy |
+12,675
| New | +$228K | 0.01% | 1685 |
|
|
2020
Q1 | – | Sell |
-801
| Closed | -$19K | – | 4386 |
|
|
2019
Q4 | $19K | Sell |
801
-770
| -49% | -$18.3K | ﹤0.01% | 1975 |
|
|
2019
Q3 | $42K | Buy |
+1,571
| New | +$42K | ﹤0.01% | 1931 |
|
|
2019
Q2 | – | Sell |
-449
| Closed | -$16K | – | 4644 |
|
|
2019
Q1 | $16K | Buy |
+449
| New | +$16K | ﹤0.01% | 2422 |
|
|
2018
Q4 | – | Sell |
-75
| Closed | -$2K | – | 4634 |
|
|
2018
Q3 | $2K | Buy |
+75
| New | +$2K | ﹤0.01% | 3522 |
|
|
2018
Q2 | – | Sell |
-145
| Closed | -$5K | – | 4304 |
|
|
2018
Q1 | $5K | Buy |
+145
| New | +$5K | ﹤0.01% | 2746 |
|
|
2017
Q4 | – | Sell |
-3,223
| Closed | -$174K | – | 4396 |
|
|
2017
Q3 | $174K | Buy |
3,223
+3,120
| +3,029% | +$168K | 0.01% | 874 |
|
|
2017
Q2 | $6K | Buy |
103
+3
| +3% | +$175 | ﹤0.01% | 1941 |
|
|
2017
Q1 | $4K | Sell |
100
-2,789
| -97% | -$112K | ﹤0.01% | 2392 |
|
|
2016
Q4 | $65K | Buy |
2,889
+1,021
| +55% | +$23K | 0.01% | 1247 |
|
|
2016
Q3 | $43K | Buy |
1,868
+1,468
| +367% | +$33.8K | ﹤0.01% | 1230 |
|
|
2016
Q2 | $9K | Buy |
+400
| New | +$9K | ﹤0.01% | 2964 |
|
|
2016
Q1 | – | Sell |
-256
| Closed | -$13K | – | 5302 |
|
|
2015
Q4 | $13K | Buy |
+256
| New | +$13K | ﹤0.01% | 1833 |
|
|
2015
Q3 | – | Sell |
-1,140
| Closed | -$52K | – | 5173 |
|
|
2015
Q2 | $52K | Sell |
1,140
-1,640
| -59% | -$74.8K | ﹤0.01% | 1337 |
|
|
2015
Q1 | $106K | Buy |
+2,780
| New | +$106K | 0.01% | 840 |
|
|
2014
Q3 | – | Sell |
-456
| Closed | -$13K | – | 5112 |
|
|
2014
Q2 | $13K | Sell |
456
-5
| -1% | -$143 | ﹤0.01% | 2172 |
|
|
2014
Q1 | $12K | Sell |
461
-3,067
| -87% | -$79.8K | ﹤0.01% | 2459 |
|
|
2013
Q4 | $91K | Buy |
3,528
+753
| +27% | +$19.4K | 0.02% | 920 |
|
|
2013
Q3 | $74K | Buy |
2,775
+418
| +18% | +$11.1K | 0.01% | 1571 |
|
|
2013
Q2 | $58K | Buy |
+2,357
| New | +$58K | ﹤0.01% | 822 |
|